Orthofix Medical Inc OFIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OFIX is a good fit for your portfolio.
News
-
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
-
Orthofix Names Andres Cedron as New Chief Legal Officer
-
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
-
Orthofix Reports Fourth Quarter and Full Year 2023 Results
-
Orthofix Announces New President for Bone Growth Therapies Business
-
Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
-
Orthofix's stock has worst day in nearly 30 years after 3 top executives are fired for 'offensive conduct'
Trading Information
- Previous Close Price
- $13.22
- Day Range
- $13.38–13.81
- 52-Week Range
- $9.58–21.59
- Bid/Ask
- $13.54 / $13.56
- Market Cap
- $507.23 Mil
- Volume/Avg
- 161,207 / 357,328
Key Statistics
- Price/Earnings (Normalized)
- 577.49
- Price/Sales
- 0.64
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,634
- Website
- https://www.orthofix.com
Comparables
Valuation
|
Metric
|
OFIX
|
ZIMV
|
MMSI
|
|---|---|---|---|
Price/Earnings (Normalized) | 577.49 | 9.84 | 24.64 |
Price/Book Value | 0.81 | 1.06 | 3.57 |
Price/Sales | 0.64 | 0.93 | 3.44 |
Price/Cash Flow | 57.98 | 12.48 | 20.12 |
Price/Earnings
OFIX
ZIMV
MMSI
Financial Strength
|
Metric
|
OFIX
|
ZIMV
|
MMSI
|
|---|---|---|---|
Quick Ratio | 0.98 | 0.84 | 3.81 |
Current Ratio | 2.54 | 2.78 | 5.45 |
Interest Coverage | −16.23 | −1.51 | 8.07 |
Quick Ratio
OFIX
ZIMV
MMSI
Profitability
|
Metric
|
OFIX
|
ZIMV
|
MMSI
|
|---|---|---|---|
Return on Assets (Normalized) | −13.57% | 14.12% | 9.43% |
Return on Equity (Normalized) | −19.53% | 31.63% | 14.77% |
Return on Invested Capital (Normalized) | −16.16% | 18.79% | 11.47% |
Return on Assets
OFIX
ZIMV
MMSI
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pgpmsmcbx | Hpbvs | $185.8 Bil | |
SYK
| Stryker Corp | Vvvvnpkzry | Frjn | $127.4 Bil | |
MDT
| Medtronic PLC | Zgjvrtbq | Xgqkj | $105.2 Bil | |
BSX
| Boston Scientific Corp | Lgmpbtk | Bfvxfqm | $99.0 Bil | |
DXCM
| DexCom Inc | Lkvymhqxx | Jnxgv | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Knmjczbvqh | Gbgvgt | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Tzdjzqxzw | Lyhcv | $25.0 Bil | |
ALGN
| Align Technology Inc | Xshffxbz | Mgylyg | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Gjwxqxs | Fddmsfz | $18.9 Bil | |
PODD
| Insulet Corp | Tlrwwtnpzs | Bqbgh | $11.7 Bil |